Dr. Chouinard will focus on business development for the drug development facilities in Long Island, NY, purchased by RPS and most recently operated by Forest Labs.
Dr. Chouinard has more than 20 years of experience in the generic, contract development and biopharma industries, developing more than 30 solid dose products for the Canadian and European markets. Prior to joining RPS, he served as executive director of product development at Halo Pharmaceutical’s Montreal location, where he was involved in new business development opportunities and product development management.
“Francois brings a deep understanding of the drug development process,” said Mr. Dupont. “His many years of success and experience working in the CDMO/CMO environment, along with his superior customer engagement skills and scientific background, are unique and valuable assets which will advance and support our mission to provide a superior customer engagement experience.”